Q301--DONOR-DERIVED CELL FREE DNA TESTING KITS
Veterans Affairs · 242-NETWORK CONTRACT OFFICE 02 (36C242)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C24226Q0287 in this department, oldest first.
- Feb 6, 2026 · this noticeCombined Synopsis/Solicitation
- Apr 1, 2026Award NoticeEurofins Transplant Genomics, LLC · $600KOpen
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
The James J. Peters Bronx VA Medical Center (JJP VAMC) requires comprehensive donor-derived cell-free DNA (dd-cfDNA) testing kits and laboratory services to support the Renal Transplant Program. These services are intended to support post-transplant surveillance for kidney transplant recipients.
Who won similar work
7 award notices on SAM.gov in the last 24 months. Matched by: Same office (242-NETWORK CONTRACT OFFICE 02 (36C242)), same product/service code (PSC) Q301 and NAICS 621511.
Single-winner award sizes (7): middle half $665K to $2.2M, median $1.3M; range $391K to $6.8M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| QUEST DIAGNOSTICS INCORPORATED · $DGX · $9.3B | 3 | $8.1M | Jun 24, 2026 |
| LABORATORY CORPORATION | 2 | $3.7M | Oct 1, 2026 |
| THE ROGOSIN INSTITUTE INC | 2 | $2.3M | Jun 1, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $DGX reported $9.3B revenue in FY2025. The median single-winner award in these 7 past awards, $1.3M, is under 0.1% of that. 10-K
One award's total value against one year of revenue; many awards are paid over several years.
- Oct 1, 2026LABORATORY CORPORATION$1.3MQ301--CYTOPATHOLOGY AND NEXT GENERATION SEQUENCING TESTING SERVICES
- Jun 30, 2026LABORATORY CORPORATION$2.4MEMERGENCY BRIDGE- Downstate Reference Lab
- Jun 24, 2026QUEST DIAGNOSTICS INCORPORATED$675KQ301--V797D-70090 | 36C24226A0046 | URGENT Bridge Specialized Genetic and Esoteric Lab Testing FSS-BPA LSJ Attached
- Jun 1, 2026THE ROGOSIN INSTITUTE INC$2.0MQ301--Tissue Typing and Immunogenetics Lab Services
- Jun 1, 2026THE ROGOSIN INSTITUTE INC$391KQ301--Tissue Typing and Immunogenetics Lab Services
- Dec 4, 2025QUEST DIAGNOSTICS INCORPORATED$6.8MQ301--Base-Reference Laboratory Testing for VISN2 North (VA-26-00003512)
- Jun 23, 2025QUEST DIAGNOSTICS INCORPORATED$655KQ301--6-Month Bridge VISN 2 South Specialized Genetic and Esoteric Lab Testing FSS-BPA LSJ Attached
Competitive landscape
For the 3 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (0 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $22K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 1 of the past winners are listed companies
- 0 insider buys and 3 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.